Research Site

Calgary T2N 2T9

1 studies enrolling now · 5 studies all time

What they study most

Advanced Clear Cell Renal Cell Carcinoma, Cerebral Stroke, Cerebrovascular Stroke, Chronic Lymphocytic Leukemia, Ischemic Attack, Transient, Metastatic Clear Cell Renal Cell Carcinoma, Postmenopausal Osteoporosis, Severe Hemophilia A, Stroke, Acute

Studies at this site

• Study of Casdatifan and Cabozantinib Versus Placebo and Cabozantinib in Patients With Advanced Clear Cell Renal Cell Carcinoma — Recruiting now
• A Study of Acalabrutinib vs Investigator's Choice of Idelalisib Plus Rituximab or Bendamustine Plus Rituximab in R/R CLL — Running, not enrolling
• Study to Evaluate the Safety, Pharmacokinetics and Efficacy of Recombinant Factor VIII Fc Fusion Protein (rFVIIIFc) in Previously Treated Subjects With Severe Hemophilia A — Completed
• A Study of Monthly Risedronate for Osteoporosis — Completed
• Safety and Effectiveness of NXY-059 for the Treatment of Patients Who Have Suffered From a Stroke — Completed